Health
Could synNotch CAR T cells be the answer to fighting solid tumours? – Drug Target Review
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
Posted: 22 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
Researchers have developed a novel CAR T-cell therapy for neuroblastoma which uses gating to limit toxicity and T-cell exhaustion.
A novel chimeric antigen receptor T-cell (CAR T) therapy targeting neuroblastoma effectively killed cancer cells while sparing healthy tissues in pre-clinical studies. While this work is in the preclinical phase, the developers of the treatment said it opens the door for other potentially…
-
Noosa News14 hours agoPrincess Anne visits Gallipoli Barracks in Brisbane on Remembrance Day as Australian tour ends
-
General11 hours agoCar bomb outside Islamabad court kills at least five, Pakistani media says
-
Noosa News12 hours agoRoyal visit to Gallipoli Barracks in Enoggera on Remembrance Day
-
General14 hours ago‘Do you care?’: Coles stares down anti-salmon activists